TRITANIUM
Device
Stryker Corporation
Total Payments
$14.9M
Transactions
14,283
Doctors
3,620
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $641,099 | 639 | 296 |
| 2023 | $1.2M | 784 | 397 |
| 2022 | $1.6M | 1,158 | 580 |
| 2021 | $1.9M | 1,272 | 600 |
| 2020 | $1.9M | 1,338 | 486 |
| 2019 | $3.3M | 3,696 | 1,278 |
| 2018 | $4.3M | 5,396 | 1,674 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Royalty or License | $8.3M | 251 | 55.6% |
| Unspecified | $2.9M | 883 | 19.3% |
| Consulting Fee | $2.5M | 535 | 16.6% |
| Food and Beverage | $671,042 | 10,985 | 4.5% |
| Travel and Lodging | $522,949 | 1,565 | 3.5% |
| Space rental or facility fees (teaching hospital only) | $43,792 | 9 | 0.3% |
| Education | $18,113 | 50 | 0.1% |
| Long term medical supply or device loan | $2,085 | 4 | 0.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $961.02 | 1 | 0.0% |
Payments by Type
General
$12.0M
13,400 transactions
Research
$2.9M
883 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| TRIDENT II TRITANIUM OUTCOMES STUDY | Stryker Corporation | $715,253 | 1 |
| TRIATHLON TRITANIUM KNEE OUTCOMES STUDY | Stryker Corporation | $545,806 | 2 |
| TRIATHLON TRITANIUM CONE AUGMENTS OUTCOMES STUDY | Stryker Corporation | $502,653 | 3 |
| TRITANIUM PRIMARY ACETABULAR SHELL STUDY | Stryker Corporation | $280,908 | 2 |
| MAVRIC MAGNETIC RESONANCE IMAGING USED TO STUDY DETAILED BONE APPOSITION AND FIXATION OF THE STRYKER TRIATHLON CEMENTLESS KNEE SYSTEM COMPARED TO CEMENTED TOTAL KNEE REPLACEMENTS | Stryker Corporation | $103,683 | 0 |
| A PROSPECTIVE RADIOSTEREOMETRIC ANALYSIS AND CLINICAL EVALUATION OF THE TRIATHLON TRITANIUM KNEE COMPONENTS | Stryker Corporation | $91,334 | 0 |
| MAVRIC MRI USED TO STUDY DETAILED BONE APPOSITION AND FIXATION OF THE STRYKER TRIDENT II TRITANIUM SYSTEM | Stryker Corporation | $74,614 | 0 |
| MID-TERM RESULTS OF A HIGHLY POROUS TITANIUM CEMENTLESS TIBIAL | Stryker Corporation | $53,645 | 0 |
| MULTI CENTER, PROSPECTIVE EVALUATION FOR CLINICAL AND RADIOGRAPHIC OUTCOMES UTILIZING STRYKER SPINE CERVICAL AND LUMBAR INTERBODY SYSTEMS: OBSERVATIONAL POST MARKET CLINICAL FOLLOW UP STUDY | Stryker Corporation | $51,397 | 1 |
| A LONGITUDINAL MULTICENTER STUDY OF ROBOTIC ARM ASSISTED THA: ACETABULAR CUP PLACEMENT ACCURACY AND CLINICAL OUTCOMES | Stryker Corporation | $48,767 | 0 |
| CLINICAL AND COST-EFFECTIVENESS OF LUMBAR INTERBODY FUSION USING TRITANIUM POSTEROLATERAL CAGE (VS. PROPENSITY MATCHED COHORT OF PEEK CAGE) | Stryker Corporation | $47,730 | 0 |
| SURVIVORSHIP, RADIOGRAPHIC, AND FUNCTIONAL OUTCOMES OF THE MULTIHOLE REVISION ACETABULAR CUP | Stryker Corporation | $45,089 | 0 |
| EVALUATION OF FUSION WITH TRITANIUM PL CAGE USED IN MIDLINE APPROACH TO POSTERIOR LUMBAR INTERBODY FUSION | Stryker Corporation | $39,749 | 0 |
| PERFORMANCE OF POROUS TRITANIUM ACETABULAR COMPONENTS IN PRIMARY TOTAL HIP ARTHROPLASTY AT A MINIMUM OF TWO YEARS | Stryker Corporation | $32,462 | 0 |
| RI160501 OBSERVATIONAL, PROSPECTIVE COHORT STUDY THAT EVALUATES THE CLINICAL EFFECTIVENESS, MEDICAL RESOURCE CONSUMPTION, AND COST-EFFECTIVENESS OF LUMBAR INTERBODY FUSION UTILIZING A TRITANIUM PL CAGE | Stryker Corporation | $30,960 | 0 |
| 2-YEAR FOLLOW-UP OF THE TRIATHLON TRITANIUM CEMENTLESS PATELLA | Stryker Corporation | $30,645 | 0 |
| RADIOGRAPHIC FIXATION OF THE 3D PRINTED TRIDENT II TRITANIUM ACETABULAR SYSTEM IN PRIMARY TOTAL HIP ARTHROPLASTY | Stryker Corporation | $20,747 | 0 |
| RADIOGRAPHIC FINDINGS AND CLINICAL OUTCOMES EVALUATION OF THE TRITANIUM CUP IN PRIMARY TOTAL HIP REPLACEMENT PATIENTS | Stryker Corporation | $19,498 | 0 |
| COMPARISON OF CLINICAL OUTCOMES FOLLOWING ACDF WITH INSTRUMENTATION USING STRUCTURAL ALLOGRAFT VS TRITANIUM C | Stryker Corporation | $19,474 | 0 |
| METAL ION LEVELS IN STRYKER TRIDENT II TRITANIUM SYSTEM WITH MDM LINER, CERAMIC HEAD, AND ACCOLADE II OR SECURFIT ADVANCED STEMS | Stryker Corporation | $19,068 | 0 |
Top Doctors Receiving Payments for TRITANIUM — Page 145
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , PA-C | Surgical | Florham Park, NJ | $4.69 | 1 |
| , PA | Physician Assistant | Colonie, NY | $4.65 | 1 |
| , MD | Orthopaedic Surgery | Kansas City, KS | $4.42 | 1 |
| , CNP | Nurse Practitioner | Pierre, SD | $4.17 | 1 |
| , M.D | Orthopaedic Surgery | Miami Beach, FL | $4.11 | 1 |
| , M.D | Orthopaedic Surgery of the Spine | Palos Heights, IL | $4.11 | 1 |
| , MD | Orthopaedic Surgery | Travis Afb, CA | $4.08 | 1 |
| , M.D | Orthopaedic Surgery | Travis Afb, CA | $4.08 | 1 |
| , M.D | Orthopaedic Surgery | Egg Harbor Township, NJ | $4.00 | 1 |
| , MD | Neurological Surgery | Winston Salem, NC | $3.98 | 1 |
| , M.D | Neurological Surgery | Wichita Falls, TX | $3.70 | 1 |
| , MD | Orthopaedic Surgery | Hancock, MI | $3.60 | 1 |
| , MD | Orthopaedic Surgery | Glenview, IL | $3.16 | 1 |
| , MD | Orthopaedic Surgery | Naples, FL | $2.66 | 1 |
| , MD | Vascular Neurology | Marietta, GA | $2.64 | 1 |
| , M.D | Diagnostic Radiology | Marietta, GA | $2.64 | 1 |
| , D.O | Orthopaedic Surgery | Newnan, GA | $2.46 | 1 |
| Albert Dunn | Orthopaedic Surgery | Chardon, OH | $1.94 | 1 |
| Jake Schroeder | Orthopaedic Surgery | San Diego, CA | $1.78 | 1 |
| , M.D | Orthopaedic Surgery | Bethlehem, PA | $1.78 | 1 |
| , MD | Orthopaedic Surgery | Greenwood, IN | $1.73 | 1 |
Ad
Manufacturing Companies
- Stryker Corporation $14.9M
Product Information
- Type Device
- Total Payments $14.9M
- Total Doctors 3,620
- Transactions 14,283
About TRITANIUM
TRITANIUM is a device associated with $14.9M in payments to 3,620 healthcare providers, recorded across 14,283 transactions in the CMS Open Payments database. The primary manufacturer is Stryker Corporation.
Payment data is available from 2018 to 2024. In 2024, $641,099 was paid across 639 transactions to 296 doctors.
The most common payment nature for TRITANIUM is "Royalty or License" ($8.3M, 55.6% of total).
TRITANIUM is associated with 20 research studies, including "TRIDENT II TRITANIUM OUTCOMES STUDY" ($715,253).